Managing Metastatic Bone Pain: The Role of Bisphosphonates
Authors:
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 33 (4) , 462-472
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Pain management in cancer patients with bone metastases remains a challengeJournal of Pain and Symptom Management, 2004
- Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesionsThe Breast, 2003
- Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acidSeminars in Oncology, 2002
- Bisphosphonates for breast cancer2002
- METABOLIC BONE DISEASE INDUCED BY PROSTATE CANCER: RATIONALE FOR THE USE OF BISPHOSPHONATESJournal of Urology, 2001
- Bone metastases: Approaches to managementSeminars in Oncology, 2001
- Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitroBone, 2001
- Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.Journal of Clinical Oncology, 1998
- The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trialsPain, 1998
- Malignant bone pain: pathophysiology and treatmentPain, 1997